True Cell Type,Predicted Main Cell Type,Predicted Sub Cell Types,Possible Mixed Cell Types,Marker Number,Marker List,Iterations,Model,Provider,Tissue,Species,Additional Info,Conversation History
"cd8-positive, alpha-beta t cell",T Lymphocytes,"Cytotoxic Gamma-Delta (γδ) T cells (specifically, CD8+ γδ T cells or IEL-like γδ T cells), Cytotoxic CD8+ Alpha-Beta (αβ) T cells with innate-like features (e.g., Tissue-Resident Memory T cells or IELs), Activated/Adaptive Natural Killer (NK) cells with T cell-like features",,50,"KLRC2, XCL2, LINC02446, CRTAM, KLRK1, KLRC4, KLRD1, XCL1, GZMH, CD160, CD8B, NKG7, GZMA, GZMB, GZMK, CD8A, TRGC2, SLA2, TIGIT, TNFRSF9, GPR18, CCL4, PRF1, ATP8B4, APBA2, CCL4L2, DUSP4, CTSW, TMIGD2, TRGC1, CCL5, ABI3, IL21R, IFNG, CD7, CLIC3, ENTPD1, LDLRAD4, PTPN22, HOPX, GZMM, CST7, PARD6G, ZEB2, SH2D1A, LAYN, LAG3, PRKCH, AOAH, IKZF2",1,google/gemini-2.5-flash,openrouter,large intestine,human,N/A,"Final Annotation Agent: Okay, I will perform a comprehensive single-cell RNA sequencing annotation for the provided cluster of cells from human large intestine tissue. I will follow the steps outlined to identify the cell type, providing detailed reasoning at each stage. **Input Marker List (ranked by expression intensity, high to low):** KLRC2, XCL2, LINC02446, CRTAM, KLRK1, KLRC4, KLRD1, XCL1, GZMH, CD160, CD8B, NKG7, GZMA, GZMB, GZMK, CD8A, TRGC2, SLA2, TIGIT, TNFRSF9, GPR18, CCL4, PRF1, ATP8B4, APBA2, CCL4L2, DUSP4, CTSW, TMIGD2, TRGC1, CCL5, ABI3, IL21R, IFNG, CD7, CLIC3, ENTPD1, LDLRAD4, PTPN22, HOPX, GZMM, CST7, PARD6G, ZEB2, SH2D1A, LAYN, LAG3, PRKCH, AOAH, IKZF2 --- **Step 1: List the Key Functional Markers** These markers are indicative of the cellular processes and activities within the cluster. * **Cytotoxicity/Effector Function:** * **KLRC2 (NKG2C), KLRK1 (NKG2D), KLRC4 (NKG2F), KLRD1 (CD94):** These are C-type lectin-like receptors, characteristic of Natural Killer (NK) cells and certain cytotoxic T lymphocytes (CTLs). They are involved in target cell recognition and activation of cytotoxic responses. NKG2C is particularly associated with adaptive NK cells or memory-like NK cells. * **GZMH, GZMA, GZMB, GZMK, GZMM:** Granzymes are serine proteases released by cytotoxic lymphocytes (NK cells and CTLs) to induce apoptosis in target cells. The presence of multiple granzymes (especially GZMB, GZMH, GZMA, GZMK) strongly indicates cytotoxic activity. * **PRF1 (Perforin 1):** A pore-forming protein crucial for delivering granzymes into target cells, a hallmark of cytotoxic lymphocytes. * **NKG7:** A transmembrane protein expressed in cytotoxic lymphocytes, involved in granule exocytosis and cytotoxicity. * **CTSW (Cathepsin W):** A cysteine protease expressed in NK cells and T cells, potentially involved in immune regulation or granule processing. * **CST7 (Cystatin F):** A cysteine protease inhibitor, often co-expressed with cytotoxic markers, potentially regulating proteases in the immune context. * **Chemokines/Cytokines and Receptors:** * **XCL2, XCL1 (XCL1/2):** Lymphotactin, a C-C motif chemokine, primarily expressed by NK cells and CD8+ T cells, involved in recruiting immune cells. * **CCL4, CCL4L2 (MIP-1β, MIP-1βL):** C-C motif chemokines involved in recruiting various immune cells, including NK cells, T cells, and monocytes, to sites of inflammation. * **CCL5 (RANTES):** A C-C motif chemokine, potent chemoattractant for T cells, eosinophils, and basophils, and plays a role in NK cell recruitment and activation. * **IFNG (Interferon-gamma):** A critical cytokine produced by NK cells and T cells, essential for antiviral and antitumor immunity, and macrophage activation. * **IL21R (Interleukin-21 Receptor):** Receptor for IL-21, a cytokine important for NK cell maturation, T cell differentiation, and B cell activation. Its presence suggests responsiveness to IL-21. * **Immune Checkpoints/Co-stimulatory Molecules:** * **CRTAM (Class-I MHC-restricted T cell-associated molecule):** Expressed on NK cells and CD8+ T cells, involved in cell-cell adhesion and activation. * **CD160:** A receptor expressed on NK cells and T cells, can act as a co-stimulatory or co-inhibitory molecule depending on the context. * **TIGIT (T cell immunoreceptor with Ig and ITIM domains):** An inhibitory receptor expressed on NK cells and T cells, part of the CD226/CD96/TIGIT axis, involved in immune suppression. * **TNFRSF9 (CD137/4-1BB):** A co-stimulatory receptor expressed on activated T cells and NK cells, important for T cell survival and proliferation, and NK cell activation. * **LAG3 (Lymphocyte-activation gene 3):** An inhibitory receptor expressed on activated T cells and NK cells, contributing to immune exhaustion. * **Other Immune-related Functions:** * **GPR18:** A G protein-coupled receptor, potentially involved in immune cell migration and function. * **DUSP4 (Dual Specificity Phosphatase 4):** A phosphatase involved in regulating MAPK signaling pathways, often associated with immune cell activation and differentiation. * **ABI3 (Abl-interactor 3):** Involved in actin cytoskeleton organization and cell migration, relevant for immune cell function. * **PTPN22 (Protein Tyrosine Phosphatase Non-Receptor Type 22):** A phosphatase involved in regulating T cell activation and signaling. * **SH2D1A (SAP):** An adaptor protein crucial for NK cell and T cell signaling, particularly in NK-T cell interactions and cytotoxic responses. * **IKZF2 (Helios):** A transcription factor, member of the Ikaros family, often associated with regulatory T cells, but also found in activated effector T cells and NK cells. --- **Step 2: List the Key Cell Type Markers** These markers are more specific to identifying the lineage or general type of immune cell. * **T Cell Lineage Markers:** * **CD8B, CD8A:** Components of the CD8 co-receptor, defining cytotoxic T lymphocytes (CTLs). Their high expression is a strong indicator of CD8+ T cells. * **TRGC2, TRGC1:** T cell receptor gamma chain components. The presence of gamma-delta (γδ) TCR chains (TRGC1/2) indicates γδ T cells, a distinct T cell lineage often found in mucosal tissues like the intestine, known for innate-like functions and cytotoxicity. * **CD7:** A pan-T cell marker, also expressed on NK cells. * **TMIGD2 (CD28H):** A co-stimulatory molecule expressed on T cells, particularly memory T cells. * **Natural Killer (NK) Cell Lineage Markers:** * **KLRC2, KLRK1, KLRC4, KLRD1:** As mentioned above, these C-type lectin receptors are classic NK cell markers. Their co-expression with CD8A/B is interesting and points towards a specific subset. * **CD160:** Expressed on NK cells and T cells. * **NKG7:** Strongly associated with NK cells and cytotoxic T cells. * **Markers with dual expression (NK and T cells):** * **GZMH, GZMA, GZMB, GZMK, PRF1, NKG7, XCL1, XCL2, CCL4, CCL5, IFNG, TIGIT, TNFRSF9, LAG3, CRTAM, CD7, SH2D1A, IKZF2.** The co-expression of these cytotoxic and immune-regulatory markers is characteristic of both NK cells and cytotoxic T cells. --- **Step 3: Cross-reference Known Databases and Literature** The co-expression of CD8A/B with multiple NK cell receptors (KLRC2, KLRK1, KLRD1, CD160, NKG7) and gamma-delta TCR components (TRGC1/2) is highly informative. * **CD8+ T cells:** The presence of CD8A and CD8B is a definitive marker for cytotoxic T lymphocytes. The extensive list of granzymes (GZMH, GZMA, GZMB, GZMK), perforin (PRF1), and chemokines (XCL1, XCL2, CCL4, CCL5) strongly supports their cytotoxic effector function. Immune checkpoints like TIGIT and LAG3 suggest activation and potential exhaustion, common in tissue-resident T cells or those in chronic inflammatory environments. IFNG production is also characteristic of effector T cells. * **NK cells:** The high expression of KLRC2, KLRK1, KLRD1, CD160, and NKG7 are classic NK cell markers. However, the co-occurrence with CD8A/B and TRGC1/2 makes a pure NK cell annotation less likely. * **Gamma-delta (γδ) T cells:** The presence of TRGC1 and TRGC2 is a strong indicator of γδ T cells. These cells are abundant in mucosal tissues like the intestine, often exhibit innate-like cytotoxic functions, and can express NK cell receptors and CD8. * **NKT cells (Natural Killer T cells):** While NKT cells also express NK cell markers and TCRs, they typically express an invariant TCR alpha chain (e.g., Vα24-Jα18) and CD1d-restricted. The presence of TRGC1/2 points away from classical NKT cells. * **Intraepithelial Lymphocytes (IELs):** The large intestine is rich in IELs, which are a diverse population of T cells (both αβ and γδ) and NK cells residing within the epithelial layer. Many IELs, particularly γδ T cells and some αβ CD8+ T cells, exhibit innate-like cytotoxic functions, express NK cell receptors, and can be CD8αα or CD8αβ. The markers observed are highly consistent with IEL characteristics. * **Adaptive/Memory-like NK cells:** KLRC2 (NKG2C) is a marker for adaptive NK cells, which can expand clonally and show memory-like features, often in response to viral infections (e.g., CMV). These cells can also express some T cell-associated molecules. However, the strong CD8A/B and TRGC1/2 expression points more towards a T cell lineage. **Key Observation:** The most striking feature is the co-expression of **CD8A/B** (cytotoxic T cell marker), **TRGC1/2** (gamma-delta T cell marker), and multiple **NK cell receptors** (KLRC2, KLRK1, KLRD1, CD160, NKG7), along with a robust cytotoxic machinery (granzymes, perforin). This combination is highly characteristic of specific subsets of T cells, particularly those with innate-like effector functions. --- **Step 4: Determine the Most Probable General Cell Type** Based on the strong and consistent expression of CD8A/B, TRGC1/2, and the extensive cytotoxic machinery, the most probable general cell type is **T Lymphocytes**, specifically those with cytotoxic and innate-like features. The presence of NK cell receptors indicates a specialized subset of T cells rather than pure NK cells. --- **Step 5: Identify the Top 3 Most Probable Sub Cell Types** 1. **Most Likely: Cytotoxic Gamma-Delta (γδ) T cells (specifically, CD8+ γδ T cells or IEL-like γδ T cells)** * **Reasoning:** The simultaneous high expression of **TRGC1/2** (definitive γδ T cell markers), **CD8A/B** (cytotoxic T cell markers), and numerous **NK cell receptors** (KLRC2, KLRK1, KLRD1, CD160, NKG7) is a hallmark of γδ T cells, especially those found in mucosal tissues like the large intestine. Intestinal γδ T cells often express CD8 (either αβ or αα homodimer) and acquire an innate-like cytotoxic phenotype, frequently expressing NK cell-associated molecules and a broad array of granzymes (GZMA, GZMB, GZMH, GZMK) and perforin (PRF1). The presence of chemokines (XCL1, XCL2, CCL4, CCL5) and IFNG further supports their effector function. Markers like TIGIT and LAG3 suggest an activated or potentially exhausted state, common in tissue-resident lymphocytes. 2. **Second Most Likely: Cytotoxic CD8+ Alpha-Beta (αβ) T cells with innate-like features (e.g., Tissue-Resident Memory T cells or IELs)** * **Reasoning:** The strong expression of **CD8A/B** and the extensive cytotoxic machinery (granzymes, perforin, NKG7) are characteristic of cytotoxic CD8+ αβ T cells. The presence of NK cell receptors (KLRC2, KLRK1, KLRD1) in CD8+ αβ T cells can occur in specific subsets, particularly highly activated or tissue-resident memory (TRM) cells, or intraepithelial lymphocytes (IELs) in the gut. These cells can adopt an innate-like effector phenotype. However, the explicit presence of **TRGC1/2** makes γδ T cells a stronger candidate for the *most* likely, as not all CD8+ αβ T cells express γδ TCR components. If TRGC1/2 expression was lower or absent, this option would be higher. 3. **Third Most Likely: Activated/Adaptive Natural Killer (NK) cells with T cell-like features** * **Reasoning:** The high expression of multiple NK cell receptors (KLRC2, KLRK1, KLRD1, CD160, NKG7) and the robust cytotoxic machinery (granzymes, perforin) are clearly indicative of NK cell function. KLRC2 (NKG2C) is particularly associated with adaptive NK cells. However, the prominent expression of **CD8A/B** and especially **TRGC1/2** makes a pure NK cell annotation less probable. While some NK cells can express low levels of CD8α (CD8A), the co-expression of CD8B and γδ TCR chains is highly unusual for conventional NK cells and points more strongly towards a T cell lineage that has acquired NK-like characteristics. **Most Likely Subtype:** **Cytotoxic Gamma-Delta (γδ) T cells, likely a CD8+ subset, residing in the large intestine (Intraepithelial Lymphocyte-like).** --- **Step 6: Provide a Concise Summary of Your Analysis** This cell cluster from the human large intestine exhibits a highly activated and cytotoxic phenotype, characterized by the robust expression of multiple granzymes (GZMH, GZMA, GZMB, GZMK), perforin (PRF1), and NKG7. Crucially, the cluster co-expresses definitive T cell markers **CD8A** and **CD8B**, along with **TRGC1** and **TRGC2**, indicating a gamma-delta (γδ) T cell lineage. Furthermore, there is prominent expression of several Natural Killer (NK) cell receptors, including KLRC2 (NKG2C), KLRK1 (NKG2D), KLRD1 (CD94), and CD160. This unique combination of CD8, γδ TCR, and NK cell receptor expression, coupled with a strong cytotoxic effector profile and the production of chemokines (XCL1, XCL2, CCL4, CCL5) and IFNG, is highly characteristic of **cytotoxic gamma-delta (γδ) T cells**, particularly those found as Intraepithelial Lymphocytes (IELs) in mucosal tissues like the large intestine. These cells often adopt an innate-like effector function, express NK cell-associated molecules, and can be CD8+. The presence of immune checkpoints like TIGIT and LAG3 suggests their activated state within the tissue environment. **FINAL ANNOTATION COMPLETED** | Coupling Validator: Validation result: VALIDATION PASSED | Formatting Agent: ```json { ""main_cell_type"": ""T Lymphocytes"", ""sub_cell_types"": [ ""Cytotoxic Gamma-Delta (γδ) T cells (specifically, CD8+ γδ T cells or IEL-like γδ T cells)"", ""Cytotoxic CD8+ Alpha-Beta (αβ) T cells with innate-like features (e.g., Tissue-Resident Memory T cells or IELs)"", ""Activated/Adaptive Natural Killer (NK) cells with T cell-like features"" ], ""possible_mixed_cell_types"": [] } ```"
intestinal crypt stem cell,Colonic Intestinal Stem Cells,"Crypt Base Columnar (CBC) Stem Cells (LGR5+ Stem Cells), Early Progenitor Cells (Transit-Amplifying Cells), Secretory Progenitor Cells (Immature Goblet/Enteroendocrine Precursors)",,50,"AL031284.1, AC012085.1, IGFBPL1, HMGN2P6, CHCHD2P9, PPIAP40, LGR5, RPL7P54, AC010132.3, EIF5AP4, AC008694.2, COX5AP2, TDGF1, ASCL2, AC092670.1, NPM1P6, PPIAP11, AC090498.1, RPL41P1, CYCSP55, HMGN2P4, TPI1P1, RPL41P5, AL162151.2, PPIAP29, HNRNPA1P4, AC016596.2, AL603825.1, RPL9P21, AC005884.2, PPIAP31, HMGN1P36, HMGN2P41, AL035411.1, RPS26P39, FABP5P7, SDHDP6, ATP5PFP1, EEF1A1P5, RPSAP8, HMGN2P3, SLC39A2, KRT8P13, RPL21P16, RPSAP15, HMGN1P38, AF279873.1, RPL7P6, AC112491.1, AC022968.1",1,google/gemini-2.5-flash,openrouter,large intestine,human,N/A,"Final Annotation Agent: Here's a step-by-step analysis to identify the cell type based on the provided marker list: **Step 1. List the Key Functional Markers:** Upon initial review, the provided list contains a significant number of pseudogenes (indicated by 'P' or 'P' followed by a number, or by their AC/AL prefixes which often denote uncharacterized loci or pseudogenes). These are generally not informative for cell type identification as they are non-coding and often lack specific functional roles in this context. We will focus on the protein-coding genes that are known to have functional significance. * **LGR5 (Leucine-rich repeat-containing G-protein coupled receptor 5):** This is a well-established and highly specific marker for actively cycling intestinal stem cells. LGR5 is a Wnt target gene and its expression marks the crypt base columnar (CBC) stem cells in the small intestine and colon, which are responsible for maintaining the intestinal epithelium. * **ASCL2 (Achaete-scute homolog 2):** A basic helix-loop-helix (bHLH) transcription factor, ASCL2 is a critical regulator of intestinal stem cell maintenance and proliferation. It is a direct target of Wnt signaling and works in conjunction with LGR5 to define the intestinal stem cell niche. * **TDGF1 (Teratocarcinoma-derived growth factor 1, also known as Cripto-1):** While not exclusively a stem cell marker, TDGF1 is involved in embryonic development and stem cell maintenance, particularly in the context of Wnt and Nodal signaling pathways. Its presence can support a stem/progenitor cell identity. * **SLC39A2 (Solute Carrier Family 39 Member 2, also known as ZIP2):** This gene encodes a zinc transporter. While zinc transporters have diverse roles, some are implicated in cell proliferation and differentiation. Its specific role in intestinal stem cells is less defined than LGR5 or ASCL2, but it can be part of a broader metabolic signature. **Step 2. List the Key Cell Type Markers:** Given the tissue context (large intestine) and the identified functional markers, we are primarily looking for markers associated with intestinal epithelial cells, particularly stem/progenitor populations. * **LGR5:** As mentioned above, LGR5 is the quintessential marker for intestinal stem cells, specifically the crypt base columnar (CBC) cells. Its high expression is a strong indicator of this cell type. * **ASCL2:** Reinforces the stem cell identity, working in concert with LGR5. * **TDGF1:** Supports a stem/progenitor cell state, often found in rapidly proliferating or undifferentiated cells. The remaining genes in the list are either pseudogenes or uncharacterized loci (AC/AL prefixes) and do not provide specific cell type information in this context. **Step 3. Cross-reference Known Databases:** * **LGR5:** Numerous scRNA-seq studies and bulk RNA-seq analyses consistently identify LGR5 as the primary marker for intestinal stem cells in both small intestine and colon. Databases like Human Protein Atlas, GeneCards, and various scRNA-seq atlases (e.g., Tabula Sapiens, Human Cell Atlas) confirm its restricted expression to these stem cell populations within the intestine. * **ASCL2:** Similarly, ASCL2 is widely recognized as a transcriptional regulator crucial for LGR5+ intestinal stem cell maintenance. Its co-expression with LGR5 is a hallmark of these cells. * **TDGF1:** While expressed in various stem/progenitor contexts, its presence alongside LGR5 and ASCL2 in the large intestine strongly points towards an intestinal stem cell identity. **Step 4. Determine the Most Probable General Cell Type:** The overwhelming evidence from the presence of **LGR5** and **ASCL2** as the most highly expressed and specific functional markers points directly to **Intestinal Stem Cells**. These cells are responsible for the continuous renewal of the intestinal epithelium. The tissue context (large intestine) further refines this to **Colonic Intestinal Stem Cells**. **Step 5. Identify the Top 3 Most Probable Sub Cell Types:** Given the strong stem cell signature, the sub-types will likely revolve around different states or locations of intestinal stem cells. 1. **Most Probable: Crypt Base Columnar (CBC) Stem Cells (LGR5+ Stem Cells):** * **Reasoning:** LGR5 is the definitive marker for CBC stem cells, which reside at the bottom of the intestinal crypts. ASCL2 is a critical transcription factor for their maintenance. The high expression of both LGR5 and ASCL2 makes this the most probable and direct annotation. These cells are highly proliferative and multipotent, giving rise to all other epithelial cell types. 2. **Second Most Probable: Early Progenitor Cells (Transit-Amplifying Cells):** * **Reasoning:** While CBC stem cells are at the apex of the hierarchy, they give rise to rapidly dividing transit-amplifying (TA) cells. These cells still retain some stem-like characteristics and high proliferative capacity but are committed to differentiation. Some overlap in marker expression, particularly for genes involved in proliferation and Wnt signaling, can occur. However, the *high* expression of LGR5 and ASCL2 typically places the cells *before* the full TA stage, but TA cells are the immediate progeny. 3. **Third Most Probable: Secretory Progenitor Cells (Immature Goblet/Enteroendocrine Precursors):** * **Reasoning:** Intestinal stem cells differentiate into various lineages, including secretory cells (Goblet, Paneth, Enteroendocrine) and absorptive cells (Enterocytes). While LGR5+ cells are multipotent, the initial steps of differentiation involve progenitor populations. Some markers might overlap, but the primary LGR5/ASCL2 signature points more broadly to the stem cell compartment rather than a committed secretory progenitor, which would typically express markers like *MUC2* (goblet) or *CHGA* (enteroendocrine) more prominently. Without such specific lineage markers, this is a less direct fit but represents a possible downstream state. **Most Likely Subtype:** Based on the strong and specific expression of **LGR5** and **ASCL2**, the most likely subtype is **Crypt Base Columnar (CBC) Stem Cells (LGR5+ Stem Cells)**. **Step 6. Provide a Concise Summary of Your Analysis:** The cell cluster is definitively identified as **Colonic Intestinal Stem Cells**, specifically **Crypt Base Columnar (CBC) Stem Cells**. This annotation is strongly supported by the high expression of **LGR5** and **ASCL2**, which are canonical and highly specific markers for these self-renewing, multipotent cells residing at the base of intestinal crypts. TDGF1 further supports a stem/progenitor state. The remaining markers are largely pseudogenes or uncharacterized loci, which do not contribute to cell type identification. The presence of LGR5 and ASCL2 as top markers in a large intestine sample is a clear indicator of the intestinal stem cell population responsible for epithelial regeneration. FINAL ANNOTATION COMPLETED | Coupling Validator: Validation result: VALIDATION PASSED | Formatting Agent: ```json { ""main_cell_type"": ""Colonic Intestinal Stem Cells"", ""sub_cell_types"": [ ""Crypt Base Columnar (CBC) Stem Cells (LGR5+ Stem Cells)"", ""Early Progenitor Cells (Transit-Amplifying Cells)"", ""Secretory Progenitor Cells (Immature Goblet/Enteroendocrine Precursors)"" ], ""possible_mixed_cell_types"": [] } ```"
intestinal enteroendocrine cell,Enteroendocrine Cells,"L-cells, Enterochromaffin (EC) cells, Multihormonal Enteroendocrine Cells / Hybrid Enteroendocrine Cells",Hybrid L/EC Enteroendocrine Cells,50,"GCG, PCSK1, AC090679.1, UCN3, PYY, INSL5, CHGA, LCN15, SCG2, FEV, CPLX2, NKX2-2, AL133325.3, C1orf127, LINC01014, SCGN, SLC18A1, SCG3, SCG5, TPH1, MARCH4, INSM1, RTN1, CRYBA2, SNAP25, CHGB, CRMP1, KCNB2, RFX6, AMER3, SLC32A1, CDK5R2, AVPR1B, VWA5B2, AC022893.2, ABCC8, RIMBP2, AL161658.1, COL2A1, CELF3, SCT, RIIAD1, SSTR5-AS1, RGS4, ARX, PRPH, INA, F5, AP003062.3, SLC5A8",2,google/gemini-2.5-flash,openrouter,large intestine,human,N/A,"Final Annotation Agent: Here's a step-by-step analysis to identify the cell type based on the provided marker list: **Step 1. List the Key Functional Markers:** This list is rich in genes associated with neuroendocrine function, hormone production, and secretory processes. * **GCG (Glucagon):** A key hormone involved in glucose homeostasis, typically produced by alpha cells of the pancreas, but also found in enteroendocrine L-cells in the gut. * **PCSK1 (Proprotein Convertase Subtilisin/Kexin Type 1):** An enzyme involved in the proteolytic processing of prohormones and proneuropeptides into their mature, active forms. Essential for the function of many endocrine cells. * **UCN3 (Urocortin 3):** A neuropeptide belonging to the corticotropin-releasing hormone family, involved in stress response and satiety, often expressed in enteroendocrine cells. * **PYY (Peptide YY):** A peptide hormone secreted by L-cells in the gut in response to food intake, playing a role in satiety and gut motility. * **INSL5 (Insulin-like 5):** A peptide hormone primarily produced by L-cells in the colon, involved in gut motility and potentially glucose regulation. * **CHGA (Chromogranin A):** A general marker for neuroendocrine cells, involved in the packaging and storage of peptide hormones and neurotransmitters. * **SCG2 (Secretogranin II):** Another chromogranin family member, involved in the regulated secretion of hormones and neuropeptides. * **FEV (FEV Transcription Factor, ETS Family Member):** A transcription factor crucial for the development and differentiation of enteroendocrine cells, particularly serotonin-producing cells. * **CPLX2 (Complexin 2):** A synaptic protein involved in regulating neurotransmitter release, indicating a secretory function. * **NKX2-2 (NK2 Homeobox 2):** A transcription factor involved in the development of various neuroendocrine cell types, including pancreatic islet cells and enteroendocrine cells. * **SCGN (Secretagogin):** A calcium-binding protein expressed in neuroendocrine cells, involved in regulated secretion. * **SLC18A1 (Solute Carrier Family 18 Member A1, Vesicular Monoamine Transporter 1 - VMAT1):** Involved in the transport of monoamines (like serotonin) into synaptic vesicles, characteristic of neuroendocrine cells. * **SCG3 (Secretogranin III):** Another chromogranin family member, involved in secretory granule formation. * **SCG5 (Secretogranin V, Neurosecretory Protein VGF):** A neuropeptide precursor, processed into various biologically active peptides, found in neuroendocrine cells. * **TPH1 (Tryptophan Hydroxylase 1):** The rate-limiting enzyme in serotonin synthesis, a strong indicator of serotonin-producing enteroendocrine cells. * **INSM1 (Insulinoma-associated 1):** A transcription factor essential for neuroendocrine differentiation and tumor development. * **RTN1 (Reticulon 1):** Involved in endoplasmic reticulum structure and function, and potentially in neuroendocrine secretion. * **SNAP25 (Synaptosomal-Associated Protein, 25kDa):** A component of the SNARE complex, essential for vesicle fusion and neurotransmitter/hormone release. * **CHGB (Chromogranin B):** Another general neuroendocrine marker, similar to CHGA. * **CRMP1 (Collapsin Response Mediator Protein 1):** Involved in neuronal development and axon guidance, but also found in some neuroendocrine cells. * **SLC32A1 (Solute Carrier Family 32 Member A1, Vesicular GABA Transporter - VGAT):** Transports GABA into synaptic vesicles, suggesting potential GABAergic signaling. * **ABCC8 (ATP Binding Cassette Subfamily C Member 8):** Encodes a subunit of the ATP-sensitive potassium channel, critical for regulating hormone release in some endocrine cells (e.g., insulin secretion). * **SCT (Secretin):** A peptide hormone secreted by S-cells in the duodenum in response to acidic chyme, stimulating bicarbonate secretion. While primarily duodenal, its presence suggests enteroendocrine lineage. * **ARX (Aristaless Related Homeobox):** A transcription factor involved in the development of various endocrine cell types, including pancreatic alpha cells and some enteroendocrine cells. * **PRPH (Peripherin):** An intermediate filament protein found in peripheral neurons and some neuroendocrine cells. * **INA (Internexin Alpha):** Another intermediate filament protein, typically found in neurons. * **SLC5A8 (Solute Carrier Family 5 Member 8):** A sodium-coupled monocarboxylate transporter, its role in enteroendocrine cells is less defined but could be related to nutrient sensing or transport. **Step 2. List the Key Cell Type Markers:** Given the context of ""large intestine tissue,"" the functional markers strongly point towards enteroendocrine cells. * **GCG, PYY, INSL5:** These are classic markers for **L-cells**, a major enteroendocrine cell type in the large intestine, known for secreting glucagon-like peptide 1 (GLP-1), PYY, and INSL5. * **TPH1, FEV:** Strong indicators of **enterochromaffin (EC) cells**, which are the primary source of serotonin (5-HT) in the gut. * **SCT:** A marker for **S-cells**, which are primarily found in the duodenum and jejunum, but its presence here suggests a broader enteroendocrine lineage or potentially a less common S-cell presence in the large intestine. * **CHGA, CHGB, SCG2, SCGN, INSM1, PCSK1, NKX2-2, SLC18A1, SNAP25:** These are general markers for **neuroendocrine cells** or **enteroendocrine cells** in general, indicating a cell type with secretory granules and regulated hormone/neurotransmitter release. **Step 3. Cross-reference Known Databases:** Searching databases like Human Protein Atlas, NCBI Gene, and scRNA-seq atlases (e.g., Tabula Sapiens, Gut Cell Atlas) for these markers in the context of the large intestine consistently points to enteroendocrine cells. * **GCG, PYY, INSL5** are well-established markers for colonic L-cells. * **TPH1, FEV** are definitive for EC cells. * **CHGA, PCSK1, INSM1, NKX2-2** are broadly expressed across various enteroendocrine subtypes. * The co-expression of multiple peptide hormones (GCG, PYY, INSL5, UCN3, SCT) and processing enzymes (PCSK1) within the same cluster is highly characteristic of enteroendocrine cells, which are known for their ability to co-express and co-secrete multiple hormones. **Step 4. Determine the Most Probable General Cell Type:** Based on the overwhelming evidence from both functional and cell-type specific markers, the most probable general cell type is **Enteroendocrine Cells**. The presence of numerous peptide hormones, processing enzymes, neuroendocrine transcription factors, and secretory machinery components unequivocally supports this annotation. **Step 5. Identify the Top 3 Most Probable Sub Cell Types:** Given the specific markers, we can infer the presence of multiple enteroendocrine subtypes, or a cell state that co-expresses markers of different subtypes, which is common in the gut. 1. **L-cells (most likely):** The strong expression of **GCG, PYY, and INSL5** are defining features of L-cells, which are abundant in the large intestine and colon. The presence of UCN3 also supports this, as UCN3 is expressed in a subset of L-cells. 2. **Enterochromaffin (EC) cells:** The presence of **TPH1 and FEV** are highly specific markers for EC cells, which are the most numerous enteroendocrine cell type in the gut and are responsible for serotonin production. The presence of SLC18A1 (VMAT1) further supports serotonin handling. 3. **Multihormonal Enteroendocrine Cells / Precursor-like Enteroendocrine Cells:** The co-expression of markers typically associated with distinct enteroendocrine subtypes (e.g., GCG/PYY/INSL5 for L-cells, TPH1/FEV for EC cells, SCT for S-cells) suggests either a population of cells that are differentiating and haven't fully committed to a single mature subtype, or a specific multihormonal enteroendocrine cell type. The high expression of general neuroendocrine markers (CHGA, PCSK1, INSM1, NKX2-2) further supports a neuroendocrine lineage with potential for diverse hormone production. Given the high ranking of GCG, PYY, and INSL5, the most dominant phenotype within this multihormonal context is likely L-cell-like. **Most Likely Subtype:** Considering the high ranking of **GCG, PYY, and INSL5**, which are classic and highly expressed markers for L-cells, the most likely specific subtype is **L-cells**. While there's clear evidence for EC cell characteristics (TPH1, FEV), the top markers lean more heavily towards L-cell identity. It's also possible this cluster represents a mixed population or a continuum of enteroendocrine cell states, but L-cells appear to be the predominant signature. **Step 6. Provide a Concise Summary of Your Analysis:** This cell cluster from the large intestine is unequivocally identified as **Enteroendocrine Cells**. The marker list is dominated by genes associated with hormone synthesis, processing, and secretion, including general neuroendocrine markers (CHGA, PCSK1, INSM1, NKX2-2, SNAP25) and specific peptide hormones. The most prominent subtype signature within this cluster points towards **L-cells**, evidenced by the high expression of **GCG, PYY, and INSL5**. There is also strong evidence for the presence of **Enterochromaffin (EC) cell** characteristics, indicated by TPH1 and FEV, suggesting either a mixed population of L-cells and EC cells, or a multihormonal enteroendocrine cell type with a strong L-cell bias. The overall profile is highly consistent with the diverse secretory functions of enteroendocrine cells in the large intestine. FINAL ANNOTATION COMPLETED | Coupling Validator: Validation result: VALIDATION FAILED Feedback: The validation failed due to inconsistencies between the proposed annotation and the provided marker list. 1. **Marker Consistency:** * The annotation mentions ""AC090679.1"" as a marker in the ""Key Functional Markers"" section, but it does not provide any functional description or justification for its inclusion. This gene is present in the provided marker list. * Similarly, ""LCN15"", ""AL133325.3"", ""C1orf127"", ""LINC01014"", ""MARCH4"", ""CRYBA2"", ""KCNB2"", ""RFX6"", ""AMER3"", ""AVPR1B"", ""VWA5B2"", ""AC022893.2"", ""RIMBP2"", ""AL161658.1"", ""COL2A1"", ""CELF3"", ""RIIAD1"", ""SSTR5-AS1"", ""RGS4"", ""F5"", ""AP003062.3"" are listed in the provided marker list but are not discussed or integrated into the functional analysis or cell type identification in the annotation. These markers should either be discussed to support the annotation or removed from the ""Key Functional Markers"" if they are not considered relevant. 2. **Mixed Cell Type Consideration:** * The annotation correctly identifies the strong presence of both L-cell (GCG, PYY, INSL5) and EC cell (TPH1, FEV) markers. It discusses the possibility of a mixed population or multihormonal cells. This is a good observation and is handled appropriately. **Instructions for Revising the Annotation:** 1. **Integrate All Provided Markers:** Go through the provided marker list and ensure that every marker is either discussed in the ""Key Functional Markers"" section with a relevant biological function supporting the annotation, or explicitly excluded with a justification if it's deemed irrelevant or non-specific. 2. **Provide Functional Context for All Markers:** For markers like ""AC090679.1"", ""LCN15"", etc., that were present in the provided list but not discussed, research their known functions, especially in the context of large intestine tissue and neuroendocrine cells. If they support the enteroendocrine annotation, include them with a brief explanation. If they point to a different cell type or have no clear function, acknowledge this. 3. **Refine ""Key Functional Markers"" Section:** Ensure that every marker listed in this section is indeed from the *provided* marker list. 4. **Re-evaluate the ""Most Likely Subtype"" based on comprehensive marker analysis:** While the current conclusion leans towards L-cells, a more thorough integration of all provided markers might slightly shift the emphasis or strengthen the argument for a mixed population or a specific multihormonal state. | Final Annotation Agent: Thank you for the detailed feedback. I understand the need to integrate all provided markers into the analysis and provide functional context for each, or justify their exclusion. I will now revise the annotation to address these points comprehensively. Here's the updated step-by-step analysis: **Step 1. List the Key Functional Markers:** This list is rich in genes associated with neuroendocrine function, hormone production, and secretory processes. I will now address all markers from the provided list, categorizing them by their known functions or noting if their role in this context is less clear. * **Core Neuroendocrine/Enteroendocrine Markers (Hormone Synthesis, Processing, Secretion, and Transcription Factors):** * **GCG (Glucagon):** A key hormone, in the gut, produced by enteroendocrine L-cells. * **PCSK1 (Proprotein Convertase Subtilisin/Kexin Type 1):** Essential enzyme for processing prohormones and proneuropeptides into active forms in endocrine cells. * **UCN3 (Urocortin 3):** A neuropeptide, often expressed in enteroendocrine cells, involved in stress response and satiety. * **PYY (Peptide YY):** A peptide hormone secreted by L-cells in the gut, involved in satiety and gut motility. * **INSL5 (Insulin-like 5):** A peptide hormone primarily produced by L-cells in the colon, involved in gut motility and glucose regulation. * **CHGA (Chromogranin A):** A general marker for neuroendocrine cells, involved in packaging and storage of peptide hormones and neurotransmitters. * **SCG2 (Secretogranin II):** A chromogranin family member, involved in regulated secretion of hormones and neuropeptides. * **FEV (FEV Transcription Factor, ETS Family Member):** Crucial transcription factor for the development and differentiation of enteroendocrine cells, particularly serotonin-producing cells. * **CPLX2 (Complexin 2):** A synaptic protein involved in regulating neurotransmitter release, indicating a secretory function. * **NKX2-2 (NK2 Homeobox 2):** Transcription factor involved in the development of various neuroendocrine cell types, including enteroendocrine cells. * **SCGN (Secretagogin):** A calcium-binding protein expressed in neuroendocrine cells, involved in regulated secretion. * **SLC18A1 (Solute Carrier Family 18 Member A1, VMAT1):** Transporter of monoamines (e.g., serotonin) into synaptic vesicles, characteristic of neuroendocrine cells. * **SCG3 (Secretogranin III):** Chromogranin family member, involved in secretory granule formation. * **SCG5 (Secretogranin V, Neurosecretory Protein VGF):** Neuropeptide precursor, processed into active peptides, found in neuroendocrine cells. * **TPH1 (Tryptophan Hydroxylase 1):** Rate-limiting enzyme in serotonin synthesis, a strong indicator of serotonin-producing enteroendocrine cells. * **INSM1 (Insulinoma-associated 1):** Transcription factor essential for neuroendocrine differentiation. * **SNAP25 (Synaptosomal-Associated Protein, 25kDa):** Component of the SNARE complex, essential for vesicle fusion and hormone/neurotransmitter release. * **CHGB (Chromogranin B):** General neuroendocrine marker, similar to CHGA. * **SLC32A1 (Solute Carrier Family 32 Member A1, VGAT):** Transports GABA into synaptic vesicles, suggesting potential GABAergic signaling in some neuroendocrine cells. * **ABCC8 (ATP Binding Cassette Subfamily C Member 8):** Encodes a subunit of the ATP-sensitive potassium channel, critical for regulating hormone release in some endocrine cells. * **SCT (Secretin):** A peptide hormone secreted by S-cells, primarily in the duodenum, but its presence suggests enteroendocrine lineage. * **ARX (Aristaless Related Homeobox):** Transcription factor involved in the development of various endocrine cell types, including some enteroendocrine cells. * **RFX6 (Regulatory Factor X6):** A transcription factor crucial for pancreatic islet cell development and differentiation, and also implicated in enteroendocrine cell development. * **CDK5R2 (Cyclin Dependent Kinase 5 Regulatory Subunit 2):** Involved in neuronal development and function, and can play roles in neuroendocrine cell processes. * **AVPR1B (Arginine Vasopressin Receptor 1B):** A G-protein coupled receptor for vasopressin, found in various endocrine tissues and potentially involved in regulating enteroendocrine function. * **SSTR5-AS1 (Somatostatin Receptor 5 Antisense RNA 1):** An antisense RNA related to somatostatin receptor 5, which is expressed in various neuroendocrine cells and involved in hormone regulation. Its presence suggests a regulatory role related to somatostatin signaling. * **Markers with Roles in Neuronal/Neuroendocrine Structure and Function:** * **RTN1 (Reticulon 1):** Involved in endoplasmic reticulum structure and function, and potentially in neuroendocrine secretion and membrane trafficking. * **CRMP1 (Collapsin Response Mediator Protein 1):** Involved in neuronal development and axon guidance, also found in some neuroendocrine cells, suggesting shared developmental pathways or structural roles. * **PRPH (Peripherin):** An intermediate filament protein found in peripheral neurons and some neuroendocrine cells, contributing to cytoskeletal structure. * **INA (Internexin Alpha):** Another intermediate filament protein, typically found in neurons, further supporting neuronal-like characteristics of these cells. * **RIMBP2 (RIM Binding Protein 2):** Involved in synaptic vesicle release and active zone organization, reinforcing the secretory and neuronal-like features. * **Markers with Less Defined or Broader Roles in this Specific Context:** * **AC090679.1:** A long non-coding RNA (lncRNA). LncRNAs can have diverse regulatory functions, but its specific role in enteroendocrine cells is not well-characterized in current literature. Its high expression suggests a functional role, but without further context, it's difficult to pinpoint. * **LCN15 (Lipocalin 15):** A member of the lipocalin family, often involved in transport of small hydrophobic molecules. Its specific function in enteroendocrine cells is not widely established, but some lipocalins have roles in inflammation or metabolism. * **AL133325.3:** A lncRNA. Similar to AC090679.1, its specific function in enteroendocrine cells is currently unclear. * **C1orf127 (Chromosome 1 Open Reading Frame 127):** A protein-coding gene with limited functional characterization, particularly in enteroendocrine cells. * **LINC01014 (Long Intergenic Non-Protein Coding RNA 1014):** A lncRNA, similar to the other lncRNAs, its specific role here is not well-defined. * **MARCH4 (Membrane Associated Ring-CH-Type Finger 4):** An E3 ubiquitin ligase. E3 ligases are involved in protein degradation and regulation, a broad cellular process. Its specific relevance to enteroendocrine function is not immediately apparent without further context. * **CRYBA2 (Crystallin Beta A2):** Typically associated with lens structure in the eye, its expression in non-ocular tissues can sometimes indicate stress responses or other less common roles. Its specific function in enteroendocrine cells is unclear. * **KCNB2 (Potassium Voltage-Gated Channel Subfamily B Member 2):** A voltage-gated potassium channel. Ion channels are crucial for regulating membrane potential and excitability, which is vital for hormone release in neuroendocrine cells. This supports the neurosecretory phenotype. * **AMER3 (APC Membrane Recruitment Spindle Associated 3):** Involved in Wnt signaling pathway, which is important for cell proliferation and differentiation in the gut. Its specific role in mature enteroendocrine cells is less clear. * **VWA5B2 (Von Willebrand Factor A Domain Containing 5B2):** A protein with a von Willebrand factor A domain. These domains are often involved in protein-protein interactions and extracellular matrix. Its specific role in enteroendocrine cells is not well-characterized. * **AC022893.2:** A lncRNA. Similar to other lncRNAs, its specific function here is not well-defined. * **AL161658.1:** A lncRNA. Similar to other lncRNAs, its specific function here is not well-defined. * **COL2A1 (Collagen Type II Alpha 1 Chain):** Encodes a component of type II collagen, typically found in cartilage. Its expression in enteroendocrine cells is highly unusual and might indicate a rare ectopic expression, a stress response, or a potential artifact/contamination, or a very specific, uncharacterized role in the gut microenvironment. Given its primary role, it's unlikely to be a core functional marker for enteroendocrine cells. * **CELF3 (CUGBP Elav-Like Family Member 3):** An RNA binding protein involved in post-transcriptional regulation. Its specific role in enteroendocrine cells is not widely known. * **RIIAD1 (RNA Importer And Adapter 1):** Involved in RNA transport. Its specific relevance to enteroendocrine function is not immediately apparent. * **RGS4 (Regulator Of G Protein Signaling 4):** A regulator of G protein signaling, involved in modulating GPCR pathways. This is relevant for cellular signaling, including hormone responses. * **F5 (Coagulation Factor V):** A coagulation factor. Its expression in enteroendocrine cells is unexpected. It might indicate a role in local hemostasis or inflammation, or be a marker of a rare subpopulation or contamination. * **AP003062.3:** A lncRNA. Similar to other lncRNAs, its specific function here is not well-defined. * **SLC5A8 (Solute Carrier Family 5 Member 8):** A sodium-coupled monocarboxylate transporter. Its role in enteroendocrine cells could be related to nutrient sensing or transport, potentially influencing hormone release. **Step 2. List the Key Cell Type Markers:** Given the context of ""large intestine tissue,"" the functional markers strongly point towards enteroendocrine cells. * **L-cell markers:** **GCG, PYY, INSL5, UCN3**. These are classic markers for L-cells, which are abundant in the large intestine and colon, known for secreting GLP-1, PYY, and INSL5. * **Enterochromaffin (EC) cell markers:** **TPH1, FEV, SLC18A1**. These are highly specific for EC cells, the most numerous enteroendocrine cell type in the gut, responsible for serotonin production. * **S-cell marker:** **SCT**. While primarily found in the duodenum, its presence suggests a broader enteroendocrine lineage or a rare S-cell presence in the large intestine. * **General Neuroendocrine/Enteroendocrine markers:** **CHGA, CHGB, PCSK1, SCG2, SCG3, SCG5, SCGN, INSM1, NKX2-2, SNAP25, RFX6, ARX**. These indicate a cell type with neuroendocrine features, including secretory granules and regulated hormone/neurotransmitter release. **Step 3. Cross-reference Known Databases:** Searching databases like Human Protein Atlas, NCBI Gene, and scRNA-seq atlases (e.g., Tabula Sapiens, Gut Cell Atlas, Human Cell Atlas) for these markers in the context of the large intestine consistently points to enteroendocrine cells. * The co-expression of multiple peptide hormones (GCG, PYY, INSL5, UCN3, SCT) and processing enzymes (PCSK1) within the same cluster is highly characteristic of enteroendocrine cells, which are known for their ability to co-express and co-secrete multiple hormones. * The presence of transcription factors like FEV, NKX2-2, RFX6, and INSM1 further solidifies the neuroendocrine developmental program. * The lncRNAs (AC090679.1, AL133325.3, LINC01014, AC022893.2, AL161658.1, AP003062.3) are often cell-type specific and can play regulatory roles, even if their precise function is not yet fully elucidated. Their co-expression with established enteroendocrine markers suggests they are part of the enteroendocrine transcriptional landscape. * Markers like COL2A1 and F5 are unexpected for enteroendocrine cells. Their presence, especially if at lower expression levels (given their ranking is lower than core markers), could indicate minor contamination from other cell types (e.g., mesenchymal cells for COL2A1, endothelial/immune cells for F5) or a very specific, uncharacterized stress response or niche-dependent expression. However, the overwhelming majority of highly ranked markers strongly support an enteroendocrine identity. **Step 4. Determine the Most Probable General Cell Type:** Based on the overwhelming evidence from both functional and cell-type specific markers, the most probable general cell type is **Enteroendocrine Cells**. The presence of numerous peptide hormones, their processing enzymes, neuroendocrine transcription factors, and secretory machinery components unequivocally supports this annotation. The unexpected markers (COL2A1, F5) are considered minor given the strength of the enteroendocrine signature. **Step 5. Identify the Top 3 Most Probable Sub Cell Types:** Given the specific markers, we can infer the presence of multiple enteroendocrine subtypes, or a cell state that co-expresses markers of different subtypes, which is common in the gut. 1. **L-cells (most likely):** The strong expression of **GCG, PYY, and INSL5** are defining features of L-cells, which are abundant in the large intestine and colon. The presence of UCN3 also supports this, as UCN3 is expressed in a subset of L-cells. These are among the highest-ranked markers. 2. **Enterochromaffin (EC) cells:** The presence of **TPH1 and FEV** are highly specific markers for EC cells, which are the most numerous enteroendocrine cell type in the gut and are responsible for serotonin production. SLC18A1 further supports serotonin handling. These markers are also highly ranked. 3. **Multihormonal Enteroendocrine Cells / Hybrid Enteroendocrine Cells:** The co-expression of markers typically associated with distinct enteroendocrine subtypes (e.g., GCG/PYY/INSL5 for L-cells, TPH1/FEV for EC cells, SCT for S-cells) suggests a population of cells that are either in a transitional state, co-expressing multiple hormone programs, or represent a specific hybrid enteroendocrine cell type. This phenomenon is increasingly recognized in the gut, where cells can exhibit plasticity and co-express markers of different lineages. The high expression of general neuroendocrine markers (CHGA, PCSK1, INSM1, NKX2-2, RFX6) further supports a neuroendocrine lineage with the potential for diverse hormone production. Given the high ranking of both L-cell and EC cell markers, this cluster likely represents a population with significant contributions from both, possibly as a hybrid or a mixed population. **Most Likely Subtype:** Considering the very high ranking of **GCG, PYY, and INSL5** (L-cell markers) alongside **TPH1 and FEV** (EC cell markers), this cluster most likely represents **Hybrid L/EC Enteroendocrine Cells** or a population with a significant proportion of both L-cells and EC cells, potentially exhibiting multihormonal characteristics. The top markers are split between these two major enteroendocrine lineages in the large intestine. Given the high expression of GCG, PYY, and INSL5, the L-cell phenotype is very strong, but the presence of TPH1 and FEV cannot be ignored. Therefore, acknowledging the co-expression is crucial. **Step 6. Provide a Concise Summary of Your Analysis:** This cell cluster from the large intestine is unequivocally identified as **Enteroendocrine Cells**. The marker list is dominated by genes associated with hormone synthesis, processing, and secretion, including general neuroendocrine markers (CHGA, PCSK1, INSM1, NKX2-2, SNAP25, RFX6) and specific peptide hormones. The most prominent subtype signature within this cluster points towards **Hybrid L/EC Enteroendocrine Cells**, evidenced by the co-expression and high ranking of both **L-cell markers (GCG, PYY, INSL5)** and **Enterochromaffin (EC) cell markers (TPH1, FEV)**. This suggests a population that either co-expresses features of both major enteroendocrine lineages in the large intestine or is composed of a mixture of these two closely related cell types. While some markers (e.g., COL2A1, F5) are less typical, the overwhelming neuroendocrine signature confirms the primary cell identity. FINAL ANNOTATION COMPLETED | Coupling Validator: Validation result: VALIDATION PASSED The revised annotation successfully addresses the previous feedback. All markers from the provided list are now explicitly discussed, categorized, and their relevance (or lack thereof) to the enteroendocrine cell type is considered. The annotation provides a comprehensive and well-reasoned justification for the final cell type identification, including the nuanced discussion of potential mixed or hybrid populations. The identification of ""Hybrid L/EC Enteroendocrine Cells"" is a strong and well-supported conclusion given the marker profile. | Formatting Agent: ```json { ""main_cell_type"": ""Enteroendocrine Cells"", ""sub_cell_types"": [ ""L-cells"", ""Enterochromaffin (EC) cells"", ""Multihormonal Enteroendocrine Cells / Hybrid Enteroendocrine Cells"" ], ""possible_mixed_cell_types"": [ ""Hybrid L/EC Enteroendocrine Cells"" ] } ```"
monocyte,Neural Crest-Derived Cells,"Schwann Cells, Enteric Glia, Enteric Neurons","Schwann Cells (Myelinating and Non-Myelinating), Enteric Glia, Enteric Neurons",50,"NKAIN3, SPP1, CDH19, TSPAN11, PLP1, L1CAM, MYOT, IGSF11, NRXN1, SLC35F1, AL136298.1, SFRP5, Z97205.2, AL358216.1, SOX10, MEGF10, SYT10, CADM2, SLITRK2, SOX2, CRTAC1, CHL1, ZNF536, FOXD3, PTPRZ1, GRIK3, TUBB2B, CMTM5, LINC01436, TTYH1, ADARB2, CDH2, TENM3, WNT6, ATP1A2, NRXN3, KCNMB4, TMEM132B, LPL, GFRA2, CHADL, FLRT1, CHST9, GJC3, Z95114.1, RHAG, FOXD3-AS1, BMS1P10, FAM19A5, FGFBP2",1,google/gemini-2.5-flash,openrouter,large intestine,human,N/A,"Final Annotation Agent: Here's a detailed analysis to identify the cell type based on the provided marker list: **Step 1: List the Key Functional Markers** * **SPP1 (Secreted Phosphoprotein 1, Osteopontin):** Involved in cell adhesion, migration, and immune modulation. Often associated with macrophages, but also found in other cell types, including some stromal cells and cancer cells. * **PLP1 (Proteolipid Protein 1):** A major structural protein of myelin in the central and peripheral nervous systems. Highly specific for oligodendrocytes and Schwann cells. * **L1CAM (L1 Cell Adhesion Molecule):** A neuronal cell adhesion molecule involved in neuronal migration, fasciculation, and synaptic plasticity. Also expressed in some epithelial and cancer cells. * **MYOT (Myotilin):** A cytoskeletal protein found in muscle cells, particularly in Z-discs. Its presence here might indicate a muscle-related cell type or a cell with myofibroblastic characteristics. * **NRXN1 (Neurexin 1):** A presynaptic cell adhesion molecule crucial for synapse formation and function. Highly expressed in neurons. * **SOX10 (SRY-Box Transcription Factor 10):** A transcription factor essential for neural crest development, including melanocytes, Schwann cells, and glial cells. A very strong marker for neural crest-derived cells. * **MEGF10 (Multiple EGF-like Domains 10):** Involved in phagocytosis and cell adhesion. Expressed in various tissues, including nervous system. * **SYT10 (Synaptotagmin 10):** A synaptic vesicle protein involved in neurotransmitter release. Primarily expressed in neurons. * **CADM2 (Cell Adhesion Molecule 2):** A neuronal cell adhesion molecule involved in synapse formation. * **SLITRK2 (SLIT and NTRK-like Family, Member 2):** A neuronal transmembrane protein involved in neurite outgrowth and synapse formation. * **SOX2 (SRY-Box Transcription Factor 2):** A transcription factor involved in maintaining pluripotency and stem cell identity. Also expressed in neural stem cells and some glial cells. * **PTPRZ1 (Protein Tyrosine Phosphatase Receptor Type Z1):** A receptor-type protein tyrosine phosphatase expressed in the central nervous system, involved in neural development and glial cell differentiation. * **GRIK3 (Glutamate Ionotropic Receptor Kainate Type Subunit 3):** A subunit of kainate receptors, which are ionotropic glutamate receptors. Highly specific for neurons. * **TUBB2B (Tubulin Beta 2B Class IIb):** A beta-tubulin isoform predominantly expressed in the nervous system, involved in microtubule formation. * **TTYH1 (Tweety Homolog 1):** A calcium-activated chloride channel, expressed in various tissues including the nervous system. * **ADARB2 (Adenosine Deaminase RNA Specific B2):** Involved in RNA editing, particularly in the nervous system. * **CDH2 (Cadherin 2, N-cadherin):** A cell adhesion molecule important in neural development and synapse formation. * **TENM3 (Teneurin Transmembrane Protein 3):** Involved in neuronal circuit assembly and synapse formation. * **ATP1A2 (ATPase Na+/K+ Transporting Subunit Alpha 2):** A subunit of the Na+/K+-ATPase pump, expressed in various tissues, including neurons and astrocytes. * **NRXN3 (Neurexin 3):** Another neurexin family member, crucial for synapse formation. Highly expressed in neurons. * **GFRA2 (GDNF Family Receptor Alpha 2):** A co-receptor for glial cell line-derived neurotrophic factor (GDNF) family ligands, involved in neuronal survival and differentiation. * **FLRT1 (Fibronectin Leucine Rich Transmembrane Protein 1):** Involved in cell adhesion and neural development. * **CHST9 (Carbohydrate Sulfotransferase 9):** Involved in glycosaminoglycan synthesis, expressed in various tissues. * **GJC3 (Gap Junction Protein Gamma 3):** A gap junction protein, expressed in various tissues. * **FAM19A5 (Family With Sequence Similarity 19 Member A5):** A secreted protein, its function is not fully elucidated but has been linked to neuronal processes. **Step 2: List the Key Cell Type Markers** Based on the functional markers, a strong neural signature is emerging. * **Neural/Neuronal Markers:** NKAIN3, L1CAM, NRXN1, SYT10, CADM2, SLITRK2, SOX2 (neural stem/progenitor), PTPRZ1, GRIK3, TUBB2B, ADARB2, CDH2, TENM3, ATP1A2, NRXN3, GFRA2, FLRT1, FAM19A5. These genes are overwhelmingly indicative of neuronal identity, involved in synaptic function, neuronal development, and cell adhesion. * **Glial/Neural Crest Markers:** PLP1, SOX10, FOXD3. * **PLP1:** Highly specific for oligodendrocytes and Schwann cells (myelinating glia). * **SOX10:** A master regulator for neural crest development, including Schwann cells, melanocytes, and some glial populations. Its high expression is a critical indicator. * **FOXD3:** Another neural crest specifier, involved in the development of various neural crest derivatives. * **Other Markers:** * **SPP1:** While often associated with macrophages, its co-expression with strong neural/glial markers suggests a context-dependent role, possibly related to neural injury or remodeling, or even a specific subtype of glia. * **CDH19:** A cadherin, less specific but can be found in various tissues. * **TSPAN11:** A tetraspanin, involved in cell surface organization. * **MYOT:** Muscle-related, but in this context, could indicate pericytes or cells with myofibroblastic features associated with nerves. * **IGSF11:** Immunoglobulin Superfamily Member 11, involved in cell adhesion. * **SLC35F1:** Solute carrier family. * **SFRP5:** Secreted Frizzled-Related Protein 5, involved in Wnt signaling. * **Z97205.2, AL358216.1, AL136298.1, Z95114.1, FOXD3-AS1, BMS1P10:** These are largely uncharacterized or non-coding RNA markers, less informative for initial cell type identification without further context. * **CRTAC1:** Cartilage Associated Protein 1, less common in neural cells, but could be present in specific stromal or connective tissue components. * **CHL1:** Cell Adhesion Molecule L1 Like, another L1CAM family member, neuronal. * **ZNF536:** Zinc Finger Protein 536, transcription factor. * **CMTM5:** Chemokine-like Receptor 5, involved in immune regulation. * **LINC01436:** Long intergenic non-coding RNA. * **KCNMB4:** Potassium Calcium-Activated Channel Subfamily M Beta Member 4. * **TMEM132B:** Transmembrane Protein 132B. * **LPL:** Lipoprotein Lipase, involved in lipid metabolism. * **CHADL:** Chondroadherin Like. * **RHAG:** Rh Associated Glycoprotein. * **FGFBP2:** Fibroblast Growth Factor Binding Protein 2. **Step 3: Cross-reference Known Databases** A quick search using key markers like **SOX10, PLP1, L1CAM, NRXN1, FOXD3, SYT10, GRIK3, TUBB2B, CDH2, TENM3, NRXN3** in databases like Human Protein Atlas, Allen Brain Atlas, and single-cell atlases (e.g., Tabula Sapiens, PanglaoDB, CellMarker) strongly points towards **neural crest-derived cells, specifically Schwann cells or enteric neurons/glia.** * **SOX10, PLP1, FOXD3:** These are canonical markers for Schwann cells and other neural crest derivatives. PLP1 is a direct marker of myelin. * **L1CAM, NRXN1, SYT10, GRIK3, TUBB2B, CDH2, TENM3, NRXN3:** These are highly indicative of neuronal identity and synaptic function. * The co-expression of both strong glial (PLP1, SOX10) and strong neuronal (NRXN1, SYT10, GRIK3) markers is particularly interesting and suggests either a mixed population, or a cell type that shares characteristics of both, such as enteric glia or developing neural crest cells. However, the *high ranking* of PLP1 and SOX10 suggests a strong glial component. **Step 4: Determine the Most Probable General Cell Type** Given the overwhelming presence of markers for neural development, synaptic function, and myelin formation, the most probable general cell type is **Neural Crest-Derived Cells**, specifically within the **Peripheral Nervous System (PNS)**. The large intestine contains the enteric nervous system (ENS), which is derived from the neural crest and consists of both neurons and glial cells. **Step 5: Identify the Top 3 Most Probable Sub Cell Types** 1. **Schwann Cells (Myelinating and Non-Myelinating):** This is the **most likely** subtype. The high expression of **SOX10, PLP1, L1CAM, FOXD3** are all strong indicators of Schwann cells. PLP1 is a major component of myelin, suggesting myelinating Schwann cells, but SOX10 and L1CAM are also expressed in non-myelinating Schwann cells. The presence of some neuronal markers could reflect close interaction with neurons or even a degree of plasticity/developmental stage where neuronal-like features are present in glia, or a small contaminating neuronal population. However, the *prominence* of PLP1 and SOX10 makes Schwann cells highly probable. In the large intestine, Schwann cells are abundant, associated with nerve fibers. 2. **Enteric Glia:** Enteric glial cells are a specialized type of peripheral glia found in the enteric nervous system. They share many markers with Schwann cells (e.g., SOX10, FOXD3) and play crucial roles in supporting enteric neurons, maintaining gut homeostasis, and modulating immune responses. While PLP1 is more characteristic of myelinating Schwann cells, enteric glia can express some glial markers. The presence of neuronal-associated genes could reflect their close functional relationship with enteric neurons. 3. **Enteric Neurons:** While many neuronal markers are present (NRXN1, SYT10, GRIK3, TUBB2B, CDH2, TENM3, NRXN3), the very high ranking of **PLP1** and **SOX10** (which are primarily glial/neural crest stem cell markers, not mature neuronal markers) makes a pure enteric neuron population less likely as the *primary* identity of the cluster. However, a subpopulation of enteric neurons or a developmental stage with mixed features cannot be entirely ruled out, or perhaps the cluster represents a nerve bundle containing both neurons and glia. If this were a pure neuronal cluster, we would expect more specific neuronal transcription factors and fewer glial-specific myelin proteins. **Most Likely Subtype:** **Schwann Cells (likely a mix of myelinating and non-myelinating, or predominantly myelinating given PLP1's high rank).** The strong co-expression of SOX10, PLP1, and FOXD3 is highly characteristic of Schwann cells. The neuronal markers could represent either a very small contaminating neuronal population, or reflect the intimate functional relationship and shared developmental origins between Schwann cells and neurons in the peripheral nervous system, or even a specific state of Schwann cells (e.g., repair Schwann cells that transiently express some neuronal-like genes). **Step 6: Provide a Concise Summary of Your Analysis** The single-cell cluster from the human large intestine exhibits a highly distinctive gene expression profile dominated by markers of neural crest origin and peripheral nervous system components. Key markers such as **SOX10, PLP1, L1CAM, FOXD3, NRXN1, SYT10, GRIK3, TUBB2B, CDH2, and TENM3** are strongly indicative of neural cell types. The prominent expression of **PLP1** (myelin proteolipid protein) and **SOX10** (a master regulator for neural crest and Schwann cell development) points strongly towards a glial identity. While several neuronal markers are also present, their co-expression with high-ranking glial markers suggests either a mixed population or, more likely, a cell type that is intimately associated with or derived from the neural lineage with strong glial characteristics. Cross-referencing with known databases confirms that this marker signature is highly characteristic of Schwann cells. Therefore, the most probable general cell type is **Neural Crest-Derived Cells**, and the most likely specific subtype is **Schwann Cells**, potentially encompassing both myelinating and non-myelinating populations, or a developmental/activated state. FINAL ANNOTATION COMPLETED | Coupling Validator: Validation result: VALIDATION PASSED | Formatting Agent: ```json { ""main_cell_type"": ""Neural Crest-Derived Cells"", ""sub_cell_types"": [""Schwann Cells"", ""Enteric Glia"", ""Enteric Neurons""], ""possible_mixed_cell_types"": [""Schwann Cells (Myelinating and Non-Myelinating)"", ""Enteric Glia"", ""Enteric Neurons""] } ```"
plasma cell,Plasma Cell,"IgA-producing Plasma Cells, IgG-producing Plasma Cells, IgM-producing Plasma Cells",,50,"IGLL5, IGLV6-57, JCHAIN, FAM92B, IGLC3, IGLC2, IGHV3-7, IGKC, TNFRSF17, IGHG1, AC026369.3, IGHV3-23, IGKV4-1, IGKV1-5, IGHA1, IGLV3-1, IGLV2-11, MYL2, MZB1, IGHG3, IGHV3-74, IGHM, ANKRD36BP2, AMPD1, IGKV3-20, IGHA2, DERL3, AC104699.1, LINC02362, AL391056.1, LILRB4, CCL3, BMP6, UBE2QL1, LINC00309, AL133467.1, GPRC5D, FCRL5, DNAAF1, AP002852.1, AC007569.1, CXorf21, RNU1-85P, U62317.4, TXNDC5, LINC02384, CCR10, BFSP2, APOBEC3A, AC106897.1",1,google/gemini-2.5-flash,openrouter,large intestine,human,N/A,"Final Annotation Agent: Here's a detailed analysis to identify the cell type based on the provided marker list: ## Step-by-Step Cell Type Annotation ### 1. List the Key Functional Markers: The most striking feature of this marker list is the overwhelming presence of immunoglobulin genes. These genes are directly involved in antibody production and secretion, which is the primary function of plasma cells. * **IGLL5 (Immunoglobulin Lambda-Like Polypeptide 5):** A surrogate light chain component, often expressed in pre-B cells and plasma cells. Its high expression here suggests a mature B-cell lineage, specifically plasma cells. * **IGLV6-57, IGLC3, IGLC2, IGHV3-7, IGKC, IGHG1, IGHV3-23, IGKV4-1, IGKV1-5, IGHA1, IGLV3-1, IGLV2-11, IGHG3, IGHM, IGKV3-20, IGHA2:** These are various immunoglobulin variable (V), constant (C), heavy (H), and light (L) chain genes. Their high and diverse expression (including different isotypes like IgG, IgA, IgM) is a hallmark of actively antibody-producing cells. * **IGHG1, IGHG3:** Immunoglobulin heavy chain gamma 1 and 3, indicating IgG production. * **IGHA1, IGHA2:** Immunoglobulin heavy chain alpha 1 and 2, indicating IgA production. * **IGHM:** Immunoglobulin heavy chain mu, indicating IgM production. * **IGKC, IGLC2, IGLC3:** Immunoglobulin kappa and lambda light chain constant regions. * **IGHV, IGLV, IGKV:** Immunoglobulin heavy and light chain variable regions. * **JCHAIN (Joining Chain of Immunoglobulin):** A polypeptide that links immunoglobulin monomers (IgA and IgM) into polymeric forms, crucial for their secretion and function in mucosal immunity. Its high expression is highly characteristic of plasma cells, especially those producing polymeric IgA and IgM. * **TNFRSF17 (B Cell Maturation Antigen - BCMA):** A receptor expressed on plasma cells and some activated B cells, involved in B cell survival and differentiation into plasma cells. It is a well-known marker for plasma cells. * **MZB1 (Marginal Zone B and B1 Cell Specific Protein 1):** While initially associated with marginal zone B cells, MZB1 is also highly expressed in plasma cells, where it plays a role in immunoglobulin secretion and endoplasmic reticulum stress response. * **DERL3 (Derlin 3):** Involved in endoplasmic reticulum-associated degradation (ERAD), which is highly active in cells with extensive protein synthesis and secretion, such as plasma cells producing large amounts of antibodies. * **GPRC5D (G Protein-Coupled Receptor Class C Group 5 Member D):** While its exact function in plasma cells is still being elucidated, it is known to be expressed on plasma cells and is a target for multiple myeloma therapies. * **FCRL5 (Fc Receptor Like 5):** An inhibitory Fc receptor expressed on B cells and plasma cells, involved in regulating B cell activation and antibody production. * **TXNDC5 (Thioredoxin Domain Containing 5):** An ER-resident protein involved in protein folding and disulfide bond formation, consistent with the high protein synthesis demands of plasma cells. ### 2. List the Key Cell Type Markers: Based on the functional markers, the cell type is clearly within the B lymphocyte lineage, specifically terminally differentiated B cells. * **IGLL5, JCHAIN, TNFRSF17, MZB1, GPRC5D, FCRL5, DERL3, TXNDC5:** As discussed above, these are all strong indicators of plasma cell identity and function. * **LILRB4 (Leukocyte Immunoglobulin Like Receptor B4):** Also known as CD85k or ILT3, it is expressed on monocytes, dendritic cells, and some B cells/plasma cells. Its presence here, alongside strong plasma cell markers, might indicate a specific subset or activation state, or it could be a less specific marker in this context compared to the immunoglobulin genes. * **CCL3 (Chemokine (C-C motif) Ligand 3):** A chemokine that attracts various immune cells. While not exclusive to plasma cells, some plasma cell subsets can produce chemokines. ### 3. Cross-reference Known Databases: A quick search in scRNA-seq databases (e.g., Human Cell Atlas, PanglaoDB, CellMarker) for ""plasma cell"" or ""B cell"" in the large intestine consistently highlights genes like *JCHAIN, IGHA1, IGHG1, IGLC2, IGLC3, IGKC, TNFRSF17 (BCMA), MZB1, IGLL5* as definitive markers for plasma cells. The co-expression of multiple immunoglobulin heavy and light chain genes, along with the joining chain and BCMA, is unequivocally indicative of plasma cells. The presence of IgA, IgG, and IgM heavy chains suggests a diverse population of plasma cells, which is common in mucosal tissues like the large intestine. ### 4. Determine the Most Probable General Cell Type: Based on the overwhelming evidence from the marker list, the most probable general cell type is **Plasma Cell**. The high expression of numerous immunoglobulin genes (heavy, light, variable, constant regions, and multiple isotypes), JCHAIN, TNFRSF17 (BCMA), and MZB1 are all canonical markers of terminally differentiated B cells specialized in antibody production. ### 5. Identify the Top 3 Most Probable Sub Cell Types: Given that the tissue is the large intestine, a mucosal site, the predominant plasma cell types are often IgA-producing. However, the presence of IgG and IgM genes suggests a broader population. 1. **IgA-producing Plasma Cells:** This is the most likely predominant subtype in the large intestine due to the critical role of IgA in mucosal immunity. The high expression of **IGHA1** and **IGHA2**, along with **JCHAIN** (essential for polymeric IgA secretion), strongly supports this. 2. **IgG-producing Plasma Cells:** The presence of **IGHG1** and **IGHG3** indicates a significant population of IgG-secreting plasma cells. While less abundant than IgA in the gut lumen, IgG-producing plasma cells are present in the lamina propria and contribute to systemic immunity and local inflammation. 3. **IgM-producing Plasma Cells:** The expression of **IGHM** suggests the presence of IgM-secreting plasma cells. These are often found early in immune responses or in specific niches. Their presence, along with JCHAIN, indicates polymeric IgM production. **Most Likely Subtype:** Based on the context of the large intestine and the strong expression of **IGHA1, IGHA2, and JCHAIN**, the most likely predominant subtype is **IgA-producing Plasma Cells**. ### 6. Provide a Concise Summary of Your Analysis: The cell cluster is definitively identified as **Plasma Cells**. This annotation is strongly supported by the high and diverse expression of numerous immunoglobulin genes (e.g., *IGLL5, IGLV6-57, IGLC3, IGHV3-7, IGKC, IGHG1, IGHA1, IGHM*), indicating active antibody synthesis and secretion. Key plasma cell-specific markers such as **JCHAIN** (essential for polymeric IgA/IgM), **TNFRSF17 (BCMA)** (a plasma cell survival receptor), and **MZB1** (involved in immunoglobulin secretion) are also highly expressed. The presence of both IgA (IGHA1, IGHA2), IgG (IGHG1, IGHG3), and IgM (IGHM) heavy chain genes suggests a heterogeneous population of plasma cells. Given the large intestine tissue origin, **IgA-producing Plasma Cells** are the most probable predominant subtype, followed by IgG- and IgM-producing plasma cells, all contributing to mucosal immunity. FINAL ANNOTATION COMPLETED | Coupling Validator: Validation result: VALIDATION PASSED | Formatting Agent: ```json { ""main_cell_type"": ""Plasma Cell"", ""sub_cell_types"": [""IgA-producing Plasma Cells"", ""IgG-producing Plasma Cells"", ""IgM-producing Plasma Cells""], ""possible_mixed_cell_types"": [] } ```"
transit amplifying cell of large intestine,Proliferating Cells,"Intestinal Transit-Amplifying (TA) Cells, Intestinal Stem Cells (ISCs), Proliferating Immune Cells",,50,"HJURP, UBE2C, CENPA, PBK, AURKB, DLGAP5, CKAP2L, KIF2C, KIF15, BIRC5, SPC25, ASPM, KIF18B, CEP55, DEPDC1, MKI67, CDC45, CDCA5, TOP2A, PCLAF, MND1, RRM2, ZNF695, CCNB2, NUF2, SKA3, SPC24, DTL, PKMYT1, CDCA3, TTK, DIAPH3, PLK1, IQGAP3, CDK1, TK1, POLQ, GTSE1, OIP5, FOXM1, TROAP, SKA1, NEK2, CDC25C, NCAPG, PIMREG, GINS2, RAD51AP1, CDT1, CCNA2",1,google/gemini-2.5-flash,openrouter,large intestine,human,N/A,"Final Annotation Agent: Here's a detailed analysis to identify the cell type based on the provided ranked marker list: **Step 1. List the Key Functional Markers:** The overwhelming majority of genes in this list are directly involved in cell cycle progression, DNA replication, and mitosis. This immediately points towards a highly proliferative cell population. * **Cell Cycle Regulators/Kinases:** * **UBE2C:** Ubiquitin-conjugating enzyme E2 C, crucial for anaphase-promoting complex/cyclosome (APC/C) activation and degradation of mitotic cyclins. * **PBK (PDZ-binding kinase):** A mitotic kinase involved in cell cycle progression and checkpoint control. * **AURKB (Aurora Kinase B):** A key mitotic kinase essential for chromosome segregation, cytokinesis, and spindle checkpoint function. * **BIRC5 (Survivin):** A member of the inhibitor of apoptosis protein (IAP) family, also critical for chromosome segregation and cytokinesis. * **KIF2C (MCAK):** Kinesin family member 2C, involved in microtubule depolymerization and spindle dynamics during mitosis. * **KIF15, KIF18B:** Kinesin family members, often involved in spindle organization and chromosome movement. * **CEP55:** Centrosomal protein 55kDa, involved in cytokinesis. * **DEPDC1:** DEP domain containing 1, a cell cycle-regulated protein. * **MKI67 (Ki-67):** A classic proliferation marker, expressed during active phases of the cell cycle (G1, S, G2, M) but absent in G0. Its high expression is a strong indicator of actively dividing cells. * **CDC45:** Cell division cycle 45, essential for initiation of DNA replication. * **CDCA5 (Sororin):** Cohesin-associated protein, involved in sister chromatid cohesion. * **TOP2A (DNA Topoisomerase II Alpha):** Essential for DNA replication, transcription, and chromosome segregation. * **PCLAF (PCNA-associated factor):** Involved in DNA replication and repair. * **RRM2 (Ribonucleotide Reductase M2):** Catalyzes the rate-limiting step in dNTP synthesis, essential for DNA replication. * **CCNB2 (Cyclin B2):** A mitotic cyclin, essential for entry into and progression through mitosis. * **DTL (Denticleless E3 Ubiquitin Protein Ligase Homolog):** Involved in DNA damage response and cell cycle control. * **PKMYT1:** Protein kinase, membrane associated tyrosine/threonine 1, a negative regulator of CDK1. * **CDCA3:** Cell division cycle associated 3, involved in cell cycle progression. * **TTK (MPS1 kinase):** Dual specificity kinase, critical for spindle assembly checkpoint (SAC) function. * **PLK1 (Polo-like kinase 1):** A key mitotic kinase regulating multiple events in mitosis. * **CDK1 (Cyclin-dependent kinase 1):** The master regulator of M-phase entry and progression. * **TK1 (Thymidine Kinase 1):** Involved in DNA synthesis (salvage pathway), highly expressed in proliferating cells. * **POLQ (DNA Polymerase Theta):** Involved in DNA repair, particularly alternative end-joining. * **FOXM1 (Forkhead Box M1):** A transcription factor crucial for regulating the expression of many mitotic genes. * **NEK2:** NIMA-related kinase 2, involved in centrosome separation and spindle formation. * **CDC25C:** Cell division cycle 25C, a phosphatase that activates CDK1. * **NCAPG (Non-SMC Condensin I Complex, Subunit G):** Part of the condensin complex, essential for chromosome condensation. * **GINS2:** GINS complex subunit 2, part of the GINS complex essential for DNA replication initiation and elongation. * **RAD51AP1:** RAD51 associated protein 1, involved in homologous recombination and DNA repair. * **CDT1:** Chromatin licensing and DNA replication factor 1, essential for DNA replication initiation. * **CCNA2 (Cyclin A2):** Involved in both S-phase and M-phase progression. * **Centrosome/Spindle/Cytokinesis Components:** * **HJURP:** Holliday junction recognition protein, involved in centromere assembly. * **CENPA:** Centromere protein A, a histone H3 variant specific to centromeres. * **DLGAP5:** DLG associated protein 5, involved in spindle organization. * **CKAP2L:** Cytoskeleton associated protein 2 like, involved in microtubule organization. * **SPC25, SPC24:** Spindle pole body component 25 and 24, part of the NDC80 kinetochore complex. * **ASPM:** Asparagine synthetase, involved in spindle pole integrity and neurogenesis. * **NUF2:** NDC80 kinetochore complex component, essential for chromosome segregation. * **SKA3, SKA1:** Spindle and kinetochore associated 3 and 1, involved in stable microtubule-kinetochore attachments. * **OIP5:** Opa-interacting protein 5, involved in kinetochore function. * **TROAP:** Trophinin associated protein, involved in cytokinesis. * **Other Proliferation-Associated Genes:** * **ZNF695:** Zinc finger protein 695, less directly characterized in cell cycle but often co-expressed with proliferation markers. * **DIAPH3:** Diaphanous related formin 3, involved in actin cytoskeleton organization, relevant for cytokinesis. * **IQGAP3:** IQ motif containing GTPase activating protein 3, involved in cell proliferation and migration. * **PIMREG:** PIM1-regulated protein, involved in cell cycle progression. **Step 2. List the Key Cell Type Markers:** Based on the provided list, there are no specific markers for differentiated large intestine cell types (e.g., enterocytes, goblet cells, Paneth cells, enteroendocrine cells, immune cells, stromal cells). The entire list is dominated by proliferation-associated genes. This suggests that the cluster represents a population of actively dividing cells, rather than a terminally differentiated cell type. **Step 3. Cross-reference Known Databases:** A quick search of these genes (e.g., MKI67, TOP2A, AURKB, UBE2C, CCNB2, CDK1, FOXM1) in scRNA-seq databases (e.g., Human Cell Atlas, specific large intestine datasets) consistently identifies them as markers for proliferating cells, often found in crypts of the intestine. These genes are universally recognized as indicators of cell cycle activity across various tissues. **Step 4. Determine the Most Probable General Cell Type:** Given the overwhelming expression of genes involved in DNA replication, cell cycle progression, and mitosis, the most probable general cell type is **Proliferating Cells**. **Step 5. Identify the Top 3 Most Probable Sub Cell Types:** In the context of the large intestine, proliferating cells are primarily found in the crypts, which house intestinal stem cells (ISCs) and their rapidly dividing progeny (transit-amplifying cells). 1. **Most Likely: Intestinal Transit-Amplifying (TA) Cells:** These cells are highly proliferative, undergoing several rounds of division as they migrate up the crypt-villus axis. They are the primary source of the differentiated cells of the intestinal epithelium. The sheer number and high expression levels of cell cycle genes strongly point to this population. While ISCs also proliferate, TA cells represent a larger, more rapidly dividing pool. 2. **Second Most Likely: Intestinal Stem Cells (ISCs):** ISCs, located at the crypt base, are responsible for maintaining the intestinal epithelium. They are also proliferative, but typically at a slower rate than TA cells, and express specific markers like *LGR5* (which is not in the provided list). However, they also express many of the cell cycle genes listed, as they are actively dividing. Without specific ISC markers, it's harder to definitively distinguish them from TA cells solely based on proliferation markers. 3. **Third Most Likely: Proliferating Immune Cells (e.g., T cells, B cells) or Stromal Cells (e.g., fibroblasts):** While less likely to be the dominant population given the sheer number of highly expressed proliferation markers, immune cells or stromal cells in the large intestine can also proliferate, especially during inflammation or tissue repair. However, their proliferation signature would typically be accompanied by specific immune or stromal markers, which are absent here. The magnitude and breadth of the proliferation signature strongly suggest an epithelial origin. **Most Likely Subtype based on the markers:** Based on the comprehensive and highly expressed list of cell cycle genes, the most likely subtype is **Intestinal Transit-Amplifying (TA) Cells**. These cells are characterized by rapid proliferation to generate the vast number of cells needed to continuously renew the intestinal epithelium. **Step 6. Provide a Concise Summary of Your Analysis:** The provided gene list is almost exclusively composed of markers associated with cell cycle progression, DNA replication, and mitosis (e.g., MKI67, UBE2C, AURKB, TOP2A, CCNB2, CDK1, FOXM1). This indicates a highly proliferative cell population. In the context of the large intestine, such a robust proliferative signature is characteristic of cells within the intestinal crypts. Therefore, the general cell type is **Proliferating Cells**. Among the specific subtypes, **Intestinal Transit-Amplifying (TA) Cells** are the most probable, given their rapid division rate and role in epithelial renewal. Intestinal Stem Cells (ISCs) are also proliferative but typically at a lower rate and would ideally be identified by specific stem cell markers. Proliferating immune or stromal cells are less likely to be the primary population due to the lack of specific lineage markers. FINAL ANNOTATION COMPLETED | Coupling Validator: Validation result: VALIDATION PASSED | Formatting Agent: ```json { ""main_cell_type"": ""Proliferating Cells"", ""sub_cell_types"": [ ""Intestinal Transit-Amplifying (TA) Cells"", ""Intestinal Stem Cells (ISCs)"", ""Proliferating Immune Cells"" ], ""possible_mixed_cell_types"": [] } ```"
